Genfit S.A.
$9.47+0.00%(+$0.00)
TickerSpark Score
46/100
40
Valuation
50
Profitability
15
Growth
64
Health
60
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNFTF research report →
52-Week Range80% of range
Low $3.28
Current $9.47
High $11.05
Companywww.genfit.com
Genfit S. A. , a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.
- CEO
- Pascal Prigent
- IPO
- 2014
- Employees
- 180
- HQ
- Loos, FR
Price Chart
+167.51% · this period
Valuation
- Market Cap
- $474.33M
- P/E
- -4.97
- P/S
- 6.36
- P/B
- -18.07
- EV/EBITDA
- -79.07
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 26.02%
- Op Margin
- -84.25%
- Net Margin
- -127.40%
- ROE
- -596.44%
- ROIC
- -41.41%
Growth & Income
- Revenue
- $65.41M · -2.38%
- Net Income
- $-85,935,801 · -5802.44%
- EPS
- $-1.73 · -5866.67%
- Op Income
- $-58,898,931
- FCF YoY
- -287.76%
Performance & Tape
- 52W High
- $11.05
- 52W Low
- $3.28
- 50D MA
- $10.43
- 200D MA
- $6.34
- Beta
- 1.08
- Avg Volume
- 91
Get TickerSpark's AI analysis on GNFTF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GNFTF Coverage
We haven't published any research on GNFTF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GNFTF Report →Similar Companies
SPHDF+0.00%
Santhera Pharmaceuticals Holding AG
$23.25
JWCTF+0.00%
JW (Cayman) Therapeutics Co. Ltd
$0.28
NGENF-2.47%
NervGen Pharma Corp.
$3.95
BRIBF-17.43%
Brii Biosciences Limited
$0.16
NDTP-8.93%
NDT Pharmaceuticals Inc.
$0.51
SLNCF-27.02%
Silence Therapeutics plc
$1.06
MLLCF+0.00%
Molecular Partners AG
$2.55
TRGNF-15.00%
Transgene S.A.
$0.85